Literature DB >> 20476980

Concurrent use of antioxidants in cancer therapy: an update.

Halide S Akbas1, Mujgan Timur, Tomris Ozben.   

Abstract

Some chemotherapeutic agents and all radiation therapy generates reactive oxygen species (ROS), which induce apoptosis in cancer cells. As ROS play a role in drug-induced apoptosis, one might suspect that antioxidants may inhibit ROS and prevent apoptosis of cancer cells. In order to find an answer to whether or not there is any interference between the concurrent use of antioxidants and chemotherapeutic agents, we have reviewed all of the recent available literature. Except for three specific interferences, considerable data exists demonstrating an increased effectiveness, as well as decreased side effects of chemotherapeutic agents when administered with antioxidants.

Entities:  

Year:  2006        PMID: 20476980     DOI: 10.1586/1744666X.2.6.931

Source DB:  PubMed          Journal:  Expert Rev Clin Immunol        ISSN: 1744-666X            Impact factor:   4.473


  2 in total

1.  Upsides and downsides of reactive oxygen species for cancer: the roles of reactive oxygen species in tumorigenesis, prevention, and therapy.

Authors:  Subash C Gupta; David Hevia; Sridevi Patchva; Byoungduck Park; Wonil Koh; Bharat B Aggarwal
Journal:  Antioxid Redox Signal       Date:  2012-01-16       Impact factor: 8.401

2.  Effects of N-acetylcystein on bleomycin-induced apoptosis in malignant testicular germ cell tumors.

Authors:  Aysegul Cort; Mujgan Timur; Evrim Dursun; Ertan Kucuksayan; Mutay Aslan; Tomris Ozben
Journal:  J Physiol Biochem       Date:  2012-05-05       Impact factor: 4.158

  2 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.